KOUTIF THERAPEUTICS
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Their academic founders are developing an inhibitor of E3 ligase Fbxo3, which is implicated in the pathogenesis of inflammatory conditions such as neuropathic pain, bronchiolitis obliterans syndrome, irritable bowel disease, chronic obstructive pulmonary disease, rheumatoid arthritis, and acute lung injury.
KOUTIF THERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2017-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.koutiftherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Typekit Squarespace
Current Employees Featured
Founder
Official Site Inspections
http://www.koutiftherapeutics.com Semrush global rank: 5.32 M Semrush visits lastest month: 1.56 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Koutif Therapeutics"
Koutif Therapeutics - Crunchbase Company Profile
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Their academic founders are developing an inhibitor of E3 ligase …See details»
Koutif Therapeutics, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Koutif Therapeutics, LLC of Beachwood, OH. Get the latest business insights from Dun & Bradstreet.See details»
Koutif Therapeutics - Overview, News & Similar companies
Koutif Therapeutics contact info: Phone number: (216) 455-3200 Website: www.koutiftherapeutics.com What does Koutif Therapeutics do? Koutif was launched by …See details»
Our Technology — Koutif Therapeutics
If you or your organization is interested in partnering with Koutif Therapeutics, please contact us via the form above. A BioMotiv Company General Inquiries: …See details»
Koutif Therapeutics - Craft
Koutif Therapeutics is a company that aims to develop therapeutic compounds that inhibit the inflammatory cascade. Its lead compound, KT-1002, focuses on the treatment of inflammatory …See details»
Partners — Koutif Therapeutics
The for-profit accelerator of The Harrington Project, is the lead funder of Koutif Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, …See details»
Koutif Therapeutics LLC - Drug pipelines, Patents, Clinical
Explore Koutif Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, , Drug:KT-1002.See details»
Koutif Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Their academic founders are developing an inhibitor of E3 ligase Fbxo3, which is implicated in …See details»
Koutif Therapeutics 2025 Company Profile: Valuation, …
Koutif Therapeutics General Information Description. Operator of a drug discovery technology intended to fight inflammatory diseases. The company's technology specializes in inhibitor of e-three ligase ligands, which are implicated in the …See details»
Koutif Therapeutics LLC Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. ... koutiftherapeutics.com. View Complete Information. Hot Search Keywords for Koutif …See details»
Koutif Therapeutics: Employee Directory | ZoomInfo.com
Koutif Therapeutics Contact Info: Phone number: (216) 455-3200 Website: www.koutiftherapeutics.com What does Koutif Therapeutics do? Koutif was launched by …See details»
Koutif Therapeutics - Office of Innovation and Entrepreneurship
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Our academic founders are developing an inhibitor of E3 ligase Fbxo3, which is implicated in the …See details»
Koutif Therapeutics Careers, Perks + Culture - Built In
Learn more about Koutif Therapeutics. Find jobs, explore benefits, and research company culture at Built In.See details»
Koutif Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 4, 2017: Seed Round - …See details»
Koutif Therapeutics - Products, Competitors, Financials, Employees ...
Koutif Therapeutics Announces FDA Acceptance of IND Application for Novel New Treatment of IBD. Feb 20, 2019. February 20, 2019 11:00 AM Eastern Standard Time CLEVELAND--( …See details»
Koutif Therapeutics - VentureRadar
Website: https://koutiftherapeutics.com/ Develops therapeutic compounds designed to inhibit inflammation by manipulating protein degradation pathways, potentially ...See details»
Great job by my team to get this award. | Russell Wyborski - LinkedIn
We are excited to share that Koutif Therapeutics (koutiftherapeutics.com), one of our portfolio companies, received $250,000 in grant funding from the Crohn's & Colitis Foundation …See details»
Koutif Therapeutics - VentureRadar
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Our academic founders are developing an inhibitor of... ... Find out ...See details»
Koutif Therapeutics CEO, Founder, Key Executive Team, Board of ...
Koutiftherapeutics.com. Overview & Products; Financials; People; Executives 1. Koutif Therapeutics Management Team1 Team Member. Koutif Therapeutics has 1 executive. Koutif …See details»